APA (7th ed.) Citation

Wang, M., Munoz, J., Goy, A., Locke, F. L., Jacobson, C. A., Hill, B. T., . . . Zheng, L. (2020). KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. New England Journal of Medicine, 382(14), 1331. https://doi.org/10.1056/NEJMoa1914347

Chicago Style (17th ed.) Citation

Wang, M., et al. "KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma." New England Journal of Medicine 382, no. 14 (2020): 1331. https://doi.org/10.1056/NEJMoa1914347.

MLA (9th ed.) Citation

Wang, M., et al. "KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma." New England Journal of Medicine, vol. 382, no. 14, 2020, p. 1331, https://doi.org/10.1056/NEJMoa1914347.